Cluster-matched quasi-experimental study reveals that AI features improve engagement and symptoms in adults undergoing psychotherapy.
Artificial intelligence (AI) may enhance the effectiveness of routine mental health care, yet large-scale real-world evaluations remain limited. We examined whether employer-level access to AI-enabled continuous care features embedded within psychotherapy was associated with treatment engagement and symptom improvement compared with psychotherapy alone. In a preregistered, cluster-matched quasi-experimental study, adults initiating psychotherapy within an employer-sponsored behavioral health program across 25 employers with access to continuous care features were compared with participants from 75 matched employers without access. Early engagement was assessed over 7 weeks ( n = 26,208), and symptom trajectories were evaluated for up to 6 months ( n = 5518). Access to continuous care features was associated with 5% greater session attendance (rate ratio 1.05 [1.01–1.10]) and faster time to second session. Although psychotherapy alone produced substantial symptom improvement, access to AI-enabled features was associated with additional reductions in depressive and anxiety symptoms ( d = 0.15–0.16), corresponding to higher rates of reliable improvement (NNT = 25). AI-enabled augmentation may enhance therapeutic engagement and support faster symptom improvement, with effects that may translate into meaningful shifts in population mental health when deployed at scale.
No takes yet. Share an insight, caveat, or question.
Graupensperger et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: